Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.
about
Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulationImmunoexpression analysis and prognostic value of BLCAP in breast cancerIntegration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis.Identification of proteins with different abundance associated with cell migration and proliferation in leiomyoma interstitial fluid by proteomics.A panel of tumor markers, calreticulin, annexin A2, and annexin A3 in upper tract urothelial carcinoma identified by proteomic and immunological analysisApplying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma.Cancer secretomics reveal pathophysiological pathways in cancer molecular oncologyAccumulation of cyclophilin A isoforms in conditioned medium of irradiated breast cancer cells.Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers.FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast.Restructuring proteomics through verificationIon-permeable membrane for on-chip preconcentration and separation of cancer marker proteinsTumor Interstitial Fluid Formation, Characterization, and Clinical ImplicationsBuilding the Evidence Base of Blood-Based Biomarkers for Early Detection of Cancer: A Rapid Systematic Mapping Review.Advances in Proteomic Technologies and Its Contribution to the Field of CancerCervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis.Secreted proteins as a fundamental source for biomarker discovery.Characterization of breast cancer interstitial fluids by TmT labeling, LTQ-Orbitrap Velos mass spectrometry, and pathway analysis.Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.Proteomic analysis of non-small cell lung cancer tissue interstitial fluids.Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.Label-free mass spectrometry-based proteomics for biomarker discovery and validation.Proteomic analysis of tissue samples in translational breast cancer research.Coupling enrichment methods with proteomics for understanding and treating disease.Label-free proteomics identifies Calreticulin and GRP75/Mortalin as peripherally accessible protein biomarkers for spinal muscular atrophy.Proteomic profiling of the cancer cell secretome: informing clinical research.Crucial considerations for pipelines to validate circulating biomarkers for breast cancer.Profiling of microRNAs in tumor interstitial fluid of breast tumors - a novel resource to identify biomarkers for prognostic classification and detection of cancer.Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.Secreted tumor antigens - immune biomarkers for diagnosis and therapy.Multi-Segment Direct Inject nano-ESI-LTQ-FT-ICR-MS/MS For Protein Identification.Biomarkers of metastatic potential in cultured adenocarcinoma clones.P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.Combination Strategy of Quantitative Proteomics Uncovers the Related Proteins of Colorectal Cancer in the Interstitial Fluid of Colonic Tissue from the AOM-DSS Mouse Model.Multi-omic approach decodes paradoxes of the triple-negative breast cancer: lessons for predictive, preventive and personalised medicine.Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools.Patient-derived Interstitial Fluids and Predisposition to Aggressive Sporadic Breast Cancer through Collagen Remodeling and Inactivation of p53.Characterization of the Tumor Secretome from Tumor Interstitial Fluid (TIF).A modified method using the SonoPrep®ultrasonic skin permeation system for sampling human interstitial fluid is compatible with proteomic techniques
P2860
Q28477301-20BA64CC-A01B-41AE-9807-9093C17A0B4EQ31103058-FD48B822-FA9C-4D12-880B-8058E6495FC6Q31111254-EABAC99D-DF3C-4598-9350-6DDD85A11290Q33684657-1F904E47-9C4B-42D3-81D3-CC07CE589931Q33689531-D1FDF392-36DC-4A7D-BC9E-71B6FEDC111BQ33846310-289CE0C4-01B9-4EB9-8F8F-84836F6AC889Q34024261-B495CF6D-B6FD-4EB4-A9D1-EFE4CDE60262Q34279515-17A955EB-16B2-46AC-A9AA-632902D19697Q34396094-C006B40A-17D3-48A0-B5F1-B984B8684233Q34497523-321314C7-B3A6-43B1-8779-380C91B95FACQ34585479-6C1AE5F0-31A4-4721-BE47-6971429A0F53Q35622975-5C4E202F-D42F-4DE7-B1B7-2967BB078265Q35646453-80A97F4A-6539-4F43-9D43-41C64BF4AEBFQ36079639-291A0DE6-2B77-434D-8561-6E2F9440A75DQ36112651-0445A1F2-4B04-4463-A252-349D43658C49Q36297776-C7C16E2B-A72C-4382-9988-03476CF8854FQ36452973-8A7360EE-613E-4C10-BDB9-5A64007FD116Q36581928-2D811538-BB43-402D-8081-F0E7CF6A2F4AQ36596837-5B182A9D-C185-458D-A452-F530D0A1BA6CQ37116256-3DC020D3-858E-422A-9885-CE6BB10F1971Q37805245-D2CF87C0-C47E-4B6E-9F42-F09CEA16B79BQ38012172-348CA40B-CFD3-46A1-8676-8D792DFCFF01Q38212502-CDBEE89E-5866-43E0-970D-975A051F5A8BQ38293824-B52DBFC6-9246-413D-A054-4821FA1F6FDCQ38651628-5C0C915C-06A4-44E9-ACE2-695B2C0C4980Q38659528-9DAA71BE-A6A8-4B6F-9955-502D7DDECE2AQ38665032-F041DBA0-D7F5-4A7B-94D1-62DC55E4E54BQ38987546-02763791-6459-4C7D-8DBB-E328E05CDA06Q38998423-2434F627-01D8-40B4-B759-90B9EF94C5F1Q39438407-C07D6202-5D52-44A5-B062-0A3E0253B444Q41769320-7B8B37E8-186D-4B16-9C49-4A38C16135CFQ42815298-160902F2-4D0C-4798-AAAB-20705789C014Q47328492-711394D7-A49C-47AE-BE2A-53E8B4EBE6A5Q47400912-6A651A9A-BE67-4B28-9390-D34212B68C21Q47574769-485BDCBA-9E9A-491F-B999-2DF4D95BB77CQ47716837-166123CF-7047-4AAB-921F-F8FCE51B8385Q52765122-B8D1467A-529A-4067-B5F3-132A4BF7BFC8Q53022294-D2713B20-3E6E-4DDB-8847-8C90699F98A7Q57687723-1181C939-7A39-4945-9440-D5B6FE06F168
P2860
Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Up-regulated proteins in the f ...... ction of cancer of the breast.
@en
type
label
Up-regulated proteins in the f ...... ction of cancer of the breast.
@en
prefLabel
Up-regulated proteins in the f ...... ction of cancer of the breast.
@en
P2093
P2860
P1433
P1476
Up-regulated proteins in the f ...... ction of cancer of the breast.
@en
P2093
Fritz Rank
Irina Gromova
Jakob Bunkenborg
José M A Moreira
Julio E Celis
Pavel Gromov
Peter Roepstorff
Teresa Cabezon
Vera Timmermans-Wielenga
P2860
P356
10.1016/J.MOLONC.2009.11.003
P577
2009-11-23T00:00:00Z